Methylation of CpG sites in RNF180 DNA promoter prediction poor survival of gastric cancer

Oncotarget

Volumn 5, Issue 10, 2014, Pages 3173-3183

  Deng, Jingyu ^a   Liang, Han ^a   Ying, Guoguang ^a   Zhang, Rupeng ^a   Wang, Baogui ^a   Yu, Jun ^b   Fan, Daiming ^c   Hao, Xishan ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Gastric cancer; Lymph node; Methylation; Prognosis; Ring finger protein 180

Indexed keywords

DNA; RING FINGER PROTEIN; RING FINGER PROTEIN 180; UNCLASSIFIED DRUG; RING FINGER PROTEIN 180, HUMAN; UBIQUITIN PROTEIN LIGASE;

ADULT; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; CPG ISLAND; DISEASE ASSOCIATION; DNA METHYLATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROTEIN EXPRESSION; RNF180 GENE; STOMACH CANCER; SURVIVAL TIME; TUMOR SUPPRESSOR GENE; AGED; GENETICS; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; PROMOTER REGION; PROPORTIONAL HAZARDS MODEL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH TUMOR; WESTERN BLOTTING;

AGED; BLOTTING, WESTERN; CPG ISLANDS; DNA METHYLATION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROGNOSIS; PROMOTER REGIONS, GENETIC; PROPORTIONAL HAZARDS MODELS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STOMACH NEOPLASMS; UBIQUITIN-PROTEIN LIGASES;

EID: 84902103466     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.1888     Document Type: Article

References (20)

1. Kumar V, Abbas AK, Fausto N, Aster J. Robbins and cotron pathologic Basis of Disease. 8 ed. Maryland: Elsevier Inc; p. 261, 2010.
2. Mrklic I, Bendic A, Kunac N, Bezic J, Forempoher G, Durdov MG, Karaman I, Prusac IK, Pisac VP, Vilovic K, Tomic S. Her-2/neu assessment for gastric carcinoma: validation of scoring system. Hepatogastroenterology. 2012;59:300-3.
3. Yoon HM, Ryu KW, Nam BH, Cho SJ, Park SR, Lee JY, Lee JH, Kook MC, Choi IJ, Kim YW. Is the new seventh AJCC/UICC staging system appropriate for patients with gastric cancer? J Am Coll Surg. 2012;214:88-96.
4. González CA, Agudo A. Carcinogenesis, prevention and early detection of gastric cancer: where we are and where we should go. Int J Cancer. 2012;130:745-53.
5. Balastik M, Ferraguti F, Pires-da Silva A, Lee TH, Alvarez-Bolado G, Lu KP, Gruss P. Deficiency in ubiquitin ligase TRIM2 causes accumulation of neurofilament light chain and neurodegeneration. Proc Natl Acad Sci USA. 2008;105:12016-21.
6. Cheung KF, Lam CN, Wu K, Ng EK, Chong WW, Cheng AS, To KF, Fan D, Sung JJ, Yu J. Characterization of the gene structure, functional significance, and clinical application of RNF180, a novel gene in gastric cancer. Cancer. 2012;118:947-59.
7. World Health Organization, Cancer Surveillance Database. Available at: www-dep.iarc.fr.
8. World Health Organization. Fact Sheet No 297, Cancer. 2-1-2009.
9. Meyer HJ, Wilke H. Treatment strategies in gastric cancer. Dtsch Arztebl Int. 2011;108: 698-705.
10. Dicken BJ, Bigam DL, Cass C, Mackey JR, Joy AA, Hamilton SM. Gastric adenocarcinoma: review and considerations for future directions. Ann Surg. 2005;241:27-39.
11. Wang F, Sun GP, Zou YF, Hao JQ, Zhong F, Ren WJ. MicroRNAs as promising biomarkers for gastric cancer. Cancer Biomark. 2012;11:259-67.
12. Li Y, Yang Y, Lu M, Shen L. Predictive value of serum CEA, CA19-9 and CA72.4 in early diagnosis of recurrence after radical resection of gastric cancer. Hepatogastroenterology. 2011;58:2166-70.
13. Pickart CM. Mechanisms underlying ubiquitination. Annu Rev Biochem. 2001;70:503-33.
14. Ogawa M, Mizugishi K, Ishiguro A, Koyabu Y, Imai Y, Takahashi R, Mikoshiba K, Aruga J. Rines/RNF180, a novel RING finger gene-encoded product, is a membrane-bound ubiquitin ligase. Genes Cells. 2008;13:397-409.
15. Ni XG, Zhou L, Wang GQ, Liu SM, Bai XF, Liu F, Peppelenbosch MP, Zhao P. The ubiquitin-proteasome pathway mediates gelsolin protein downregulation in pancreatic cancer. Mol Med. 2008;14:582-9.
16. Wu L, Pu Z, Feng J, Li G, Zheng Z, Shen W. The ubiquitin-proteasome pathway and enhanced activity of NF-kappaB in gastric carcinoma. J Surg Oncol. 2008;97:439-44.
17. Deng J, Liang H, Sun D, Pan Y, Liu Y, Wang D. Extended lymphadenectomy improvement of overall survival of gastric cancer patients with perigastric node metastasis. Langenbeck Arch Surg. 2011;396:615-23.
18. Dolled-Filhart M, Camp RL, Kowalski DP, Smith BL, Rimm DL. Tissue microarray analysis of signal transducers and activators of transcription 3 (Stat 3) and phospho-Stat3 (Tyr705) in node-negative breast cancer shows nuclear localization is associated with a better prognosis. Clin Cancer Res. 2003;9:594-600.
19. Cho YK, Chung JW, Kim JK, Ahn YS, Kim MY, Park YO, Kim WT, Byun JH. Comparison of 7 staging systems for patients with hepatocellular carcinoma undergoing transarterial chemoembolization. Cancer. 2008;112:352-61.
20. Smith DD, Schwarz RR, Schwartz RE. Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-Population Database. J Clin Oncol. 2005;23:7114-24.